enzalutamide Articles

Astellas and Medivation file for approval of enzalutamide in Japan

24 May 2013

Medivation and Astellas debut Xtandi in USA

14 September 2012

FDA backs Medivation and Astellas' prostate cancer drug Xtandi

3 September 2012

Phase III study shows enzalutamide offers significant benefit in prostate cancer

17 August 2012

PDUFA Action Date for Astellas enzalutamide; Urogenix facility to close

7 August 2012

Astellas submits prostate cancer drug for EU approval

28 June 2012

Expanded Access Program for enzalutamide agreed with US FDA

30 May 2012

Medivation files NDA for prostate cancer drug enzalutamide

23 May 2012

Showing 1-8 of 8 articles

Go to beginning

Previous

1

Next

Go to end